157 results
8-K
EX-10.1
ICU
SeaStar Medical Holding Corporation
20 Aug 24
Entry into a Material Definitive Agreement
6:41pm
by the Company of its obligations hereunder and to the continuing satisfaction of the additional conditions specified in Section 6 of this Agreement.
(ix
424B5
ICU
SeaStar Medical Holding Corporation
20 Aug 24
Prospectus supplement for primary offering
6:37pm
additions or deletions to the defeasance or the satisfaction and discharge provisions set forth herein;
if and under what circumstances we will pay
8-K
ICU
SeaStar Medical Holding Corporation
11 Jul 24
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:15pm
of certain factors, including, without limitation, risks and uncertainties related to the satisfaction of customary closing conditions related
8-K
EX-10.1
ICU
SeaStar Medical Holding Corporation
11 Jul 24
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:15pm
Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth … or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common
8-K
EX-99.1
ICU
SeaStar Medical Holding Corporation
11 Jul 24
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:15pm
11, 2024, subject to the satisfaction of customary closing conditions. The gross proceeds from the offering are expected to be approximately $10 … of the registered direct offering and concurrent private placement, the satisfaction of customary closing conditions related to the registered direct
8-K
EX-4.2
5ifbufkwz 50ubm8
11 Jul 24
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:15pm
8-K
EX-4.1
50y5akwcd8sxu ve
11 Jul 24
SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:15pm
424B5
aj1t7 qsamsuewupe0d
11 Jul 24
Prospectus supplement for primary offering
9:00am
424B3
dk56i
5 Mar 24
Prospectus supplement
5:06pm
424B3
k7b171o3 sn6yppm499l
5 Mar 24
Prospectus supplement
5:01pm